Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04074746
Title Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

B-cell lymphoma

mycosis fungoides

peripheral T-cell lymphoma

Hodgkin's lymphoma

anaplastic large cell lymphoma


Cyclophosphamide + Fludarabine


Age Groups: adult | child | senior
Covered Countries USA

No variant requirements are available.